Pennsylvania officials continue to retool the state’s vaccination plan to fall in line with recommendations from federal groups and further define who can get the vaccine and when, releasing the ...
Success by nearly all measures with Praxis Precision Medicines Inc.’s essential tremor phase III candidate, ulixacaltamide, drove the company’s stock up by more than 200% and provided supportive data ...
HONG KONG--(BUSINESS WIRE)--Cavion, Inc., a leading clinical stage biotechnology company committed to developing novel therapeutics for people with neurological diseases, today announced promising ...
CHARLOTTESVILLE, Va. & CAMBRIDGE, Mass.--(BUSINESS WIRE)--Cavion, Inc., a leading clinical stage biotechnology company committed to developing novel therapeutics for people with neurological diseases, ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback